Literature DB >> 3016260

The mechanism of action of the gastric acid secretion inhibitor omeprazole.

P Lindberg, P Nordberg, T Alminger, A Brändström, B Wallmark.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3016260     DOI: 10.1021/jm00158a001

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  37 in total

1.  Strategies for discovering and derisking covalent, irreversible enzyme inhibitors.

Authors:  Douglas S Johnson; Eranthie Weerapana; Benjamin F Cravatt
Journal:  Future Med Chem       Date:  2010-06       Impact factor: 3.808

Review 2.  Gastric H,K-ATPase as a drug target.

Authors:  Jai Moo Shin; George Sachs
Journal:  Dig Dis Sci       Date:  2006-04-28       Impact factor: 3.199

Review 3.  The gastric H,K ATPase as a drug target: past, present, and future.

Authors:  George Sachs; Jai Moo Shin; Olga Vagin; Nils Lambrecht; Iskandar Yakubov; Keith Munson
Journal:  J Clin Gastroenterol       Date:  2007-07       Impact factor: 3.062

4.  Antibacterial activity of pantoprazole and omeprazole against Helicobacter pylori.

Authors:  S Suerbaum; H Leying; K Klemm; W Opferkuch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-02       Impact factor: 3.267

5.  Comparative bioavailability study of two oral omeprazole formulations after single and repeated administrations in healthy volunteers.

Authors:  T Duvauchelle; L Millerioux; V Gualano; E Evene; A Alcaide
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

6.  Demonstration of the electrogenicity of proton translocation during the phosphorylation step in gastric H+K(+)-ATPase.

Authors:  H T van der Hijden; E Grell; J J de Pont; E Bamberg
Journal:  J Membr Biol       Date:  1990-04       Impact factor: 1.843

7.  Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H. pylori cells.

Authors:  K Nagata; H Satoh; T Iwahi; T Shimoyama; T Tamura
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

8.  Benzimidazole covalent probes and the gastric H(+)/K(+)-ATPase as a model system for protein labeling in a copper-free setting.

Authors:  Chelsea J Paresi; Qi Liu; Yue-Ming Li
Journal:  Mol Biosyst       Date:  2016-05

9.  Effect of omeprazole, an inhibitor of H+,K(+)-ATPase, on bone resorption in humans.

Authors:  K Mizunashi; Y Furukawa; K Katano; K Abe
Journal:  Calcif Tissue Int       Date:  1993-07       Impact factor: 4.333

10.  Beyond picomolar affinities: quantitative aspects of noncovalent and covalent binding of drugs to proteins.

Authors:  Adam J T Smith; Xiyun Zhang; Andrew G Leach; K N Houk
Journal:  J Med Chem       Date:  2009-01-22       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.